These emerging therapies , Retatrutide, represent a groundbreaking advancement in treating type 2 diabetes and conceivably other ailments . They are grouped as GLP-1 receptor agonists , meaning they function to emulate the natural GLP-1 substance , enhancing glucose release and suppressing food i